TFF1 and TFF3 mRNAs Are Higher in Blood from Breast Cancer Patients with Metastatic Disease than Those without

Figure 2

ROC curve illustrates performance analysis of TFF1 and TFF3 mRNA level within metastatic and nonmetastatic groups.